![]()
yahoo | Hepion Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders - Yahoo Finance |
yahoo | Anti-Cancer Mechanism of Hepion Pharmaceuticals’ CRV431 Highlighted in Scripps Research Institute Poster at AASLD, The Liver Meeting® 2021 - Yahoo Finance |
yahoo | Hepion Pharmaceuticals to Present CRV431 Preclinical Data at the 2020 Digital International Liver Congress - Yahoo Finance |
yahoo | Hepion Pharmaceuticals Announces First NASH Patient Dosed with CRV431 in Phase 2 'AMBITION' Clinical Trial - Yahoo Finance |
yahoo | Hepion Pharmaceuticals Announces Preclinical Data Supporting Novel Two-Pronged Approach to Treating COVID-19 with CRV431 - Yahoo Finance |
yahoo | Hepion Pharmaceuticals Announces Advancement to Final Dose Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431 - Yahoo Finance |
yahoo | Hepion Pharmaceuticals Announces Advancement to Fourth Dose Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431 - Yahoo Finance |
yahoo | Hepion Pharmaceuticals' CRV431 Demonstrates Efficacy in Human Idiopathic Pulmonary Fibrosis Translational Research Study - Yahoo Finance |
benzinga | 30 Stocks Moving in Wednesday's Pre-Market Session |
zacks | Biotech Stock Roundup: EPZM Drug Gets FDA Nod, XLRN & HEPA Surge on Study Data |
yahoo | Hepion Pharmaceuticals Presents Update on CRV431 Nonclinical Studies at NASH-TAG 2020 Conference - Yahoo Finance |
yahoo | Hepion Pharmaceuticals Announces Publication in Expert Opinion on Investigational Drugs - Yahoo Finance |
nasdaq | Zacks.com featured highlights include: JBGS, NWBI, THG, HEPA and HSII |
yahoo | Zacks.com featured highlights include: NWBI, THG, RUBI, HEPA and KOF |
yahoo | Hepion Pharmaceuticals Announces Canadian Research Team’s Academic Appointments - Yahoo Finance |
yahoo | Hepion Pharmaceuticals to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference - Yahoo Finance |
